Haemonetics Reported First Quarter Fiscal 2021 Financial Results
Haemonetics Reported First Quarter Fiscal 2021 Financial Results
themarketsignal.com/Free-Report/HAE
RSI of Haemonetics Corporation (NYSE:HAE) is 19.96 and the stock looks bullish. The company reported financial results for first quarter of fiscal 2021. In Q1-21 the company reported $196 million revenue, decreasing 18% from a year before. There has been a 16% organic revenue decline. The earnings per diluted share in Q1-21 came in at $0.21. During the first quarter of fiscal 2021, the adjusted earnings per diluted share came in at $0.46.
The company generated $12 million Cash flow from operating activities during the first quarter of fiscal 2021. Free cash flow before restructuring & turnaround during the reported quarter came in at $11 million.
The company also reported 46.0% gross margin in Q1-21, down 260 basis points in comparison with Q1-20.
themarketsignal.com/Free-Report/HAE
RSI of Haemonetics Corporation (NYSE:HAE) is 19.96 and the stock looks bullish. The company reported financial results for first quarter of fiscal 2021. In Q1-21 the company reported $196 million revenue, decreasing 18% from a year before. There has been a 16% organic revenue decline. The earnings per diluted share in Q1-21 came in at $0.21. During the first quarter of fiscal 2021, the adjusted earnings per diluted share came in at $0.46.
The company generated $12 million Cash flow from operating activities during the first quarter of fiscal 2021. Free cash flow before restructuring & turnaround during the reported quarter came in at $11 million.
The company also reported 46.0% gross margin in Q1-21, down 260 basis points in comparison with Q1-20.